These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38352977)

  • 1. Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β-adrenergic receptors.
    van Weperen VYH; Hoang JD; Jani NR; Khaky A; Herring N; Smith C; Vaseghi M
    J Physiol; 2024 Feb; ():. PubMed ID: 38352977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid measurement of cardiac neuropeptide dynamics by capacitive immunoprobe in the porcine heart.
    Kluge N; Dacey M; Hadaya J; Shivkumar K; Chan SA; Ardell JL; Smith C
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H66-H76. PubMed ID: 33095651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.
    Hoang JD; Salavatian S; Yamaguchi N; Swid MA; David H; Vaseghi M
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32493842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
    Poncet MF; Tavernier G; Damase-Michel C; Tran MA; Berlan M; Montastruc JL; Montastruc P
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1239-41. PubMed ID: 1659347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y (NPY) and the pig heart: release and coronary vasoconstrictor effects.
    Rudehill A; Sollevi A; Franco-Cereceda A; Lundberg JM
    Peptides; 1986; 7(5):821-6. PubMed ID: 3025824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Theodorsson-Norheim E; Hamberger B
    Neurosci Lett; 1986 Jan; 63(1):96-100. PubMed ID: 3005926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
    Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
    J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y and non-adrenergic sympathetic vascular control of the cat nasal mucosa.
    Lundblad L; Anggard A; Saria A; Lundberg JM
    J Auton Nerv Syst; 1987 Oct; 20(3):189-97. PubMed ID: 3693801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.
    Pernow J; Lundberg JM
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):379-85. PubMed ID: 2555719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen.
    Lundberg JM; Rudehill A; Sollevi A
    Eur J Pharmacol; 1989 Apr; 163(1):103-13. PubMed ID: 2744085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuropeptide Y (NPY) on isolated guinea-pig heart.
    Wahlestedt C; Wohlfart B; Håkanson R
    Acta Physiol Scand; 1987 Apr; 129(4):459-63. PubMed ID: 3591369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic innervation alters activation of pacemaker current (If) in rat ventricle.
    Qu J; Cohen IS; Robinson RB
    J Physiol; 2000 Aug; 526 Pt 3(Pt 3):561-9. PubMed ID: 10922008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Hamberger B
    Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against differential release of noradrenaline, neuropeptide Y, and dopamine-beta-hydroxylase from adrenergic nerves in the isolated perfused sheep spleen.
    De Potter WP; Kurzawa R; Miserez B; Coen EP
    Synapse; 1995 Feb; 19(2):67-76. PubMed ID: 7725244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
    Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
    J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.